201 related articles for article (PubMed ID: 18701714)
1. The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo.
Lechmann M; Shuman N; Wakeham A; Mak TW
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11887-92. PubMed ID: 18701714
[TBL] [Abstract][Full Text] [Related]
2. CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo.
Prazma CM; Yazawa N; Fujimoto Y; Fujimoto M; Tedder TF
J Immunol; 2007 Oct; 179(7):4550-62. PubMed ID: 17878352
[TBL] [Abstract][Full Text] [Related]
3. CD83 regulates lymphocyte maturation, activation and homeostasis.
Breloer M; Fleischer B
Trends Immunol; 2008 Apr; 29(4):186-94. PubMed ID: 18329338
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells.
Zinser E; Naumann R; Wild AB; Michalski J; Deinzer A; Stich L; Kuhnt C; Steinkasserer A; Knippertz I
Front Immunol; 2019; 10():1442. PubMed ID: 31293592
[TBL] [Abstract][Full Text] [Related]
5. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells.
Lüthje K; Cramer SO; Ehrlich S; Veit A; Steeg C; Fleischer B; Bonin Av; Breloer M
Eur J Immunol; 2006 Aug; 36(8):2035-45. PubMed ID: 16841299
[TBL] [Abstract][Full Text] [Related]
6. CD83 Modulates B Cell Activation and Germinal Center Responses.
Krzyzak L; Seitz C; Urbat A; Hutzler S; Ostalecki C; Gläsner J; Hiergeist A; Gessner A; Winkler TH; Steinkasserer A; Nitschke L
J Immunol; 2016 May; 196(9):3581-94. PubMed ID: 26983787
[TBL] [Abstract][Full Text] [Related]
7. CD83: a regulatory molecule of the immune system with great potential for therapeutic application.
Fujimoto Y; Tedder TF
J Med Dent Sci; 2006 Jun; 53(2):85-91. PubMed ID: 16913569
[TBL] [Abstract][Full Text] [Related]
8. CD83 orchestrates immunity toward self and non-self in dendritic cells.
Wild AB; Krzyzak L; Peckert K; Stich L; Kuhnt C; Butterhof A; Seitz C; Mattner J; Grüner N; Gänsbauer M; Purtak M; Soulat D; Winkler TH; Nitschke L; Zinser E; Steinkasserer A
JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31527313
[TBL] [Abstract][Full Text] [Related]
9. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
10. Engagement of CD83 on B cells modulates B cell function in vivo.
Kretschmer B; Lüthje K; Schneider S; Fleischer B; Breloer M
J Immunol; 2009 Mar; 182(5):2827-34. PubMed ID: 19234177
[TBL] [Abstract][Full Text] [Related]
11. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells.
Cao W; Lee SH; Lu J
Biochem J; 2005 Jan; 385(Pt 1):85-93. PubMed ID: 15320871
[TBL] [Abstract][Full Text] [Related]
12. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.
Lechmann M; Krooshoop DJ; Dudziak D; Kremmer E; Kuhnt C; Figdor CG; Schuler G; Steinkasserer A
J Exp Med; 2001 Dec; 194(12):1813-21. PubMed ID: 11748282
[TBL] [Abstract][Full Text] [Related]
13. Activated T cells induce rapid CD83 expression on B cells by engagement of CD40.
Kretschmer B; Kühl S; Fleischer B; Breloer M
Immunol Lett; 2011 May; 136(2):221-7. PubMed ID: 21277328
[TBL] [Abstract][Full Text] [Related]
14. Membrane-bound and soluble porcine CD83 functions antithetically in T cell activation and dendritic cell differentiation in vitro.
Huo S; Zhang J; Liang S; Wu F; Zuo Y; Cui D; Zhang Y; Zhong Z; Zhong F
Dev Comp Immunol; 2019 Oct; 99():103398. PubMed ID: 31121186
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
16. CD83 expression in CD4+ T cells modulates inflammation and autoimmunity.
Reinwald S; Wiethe C; Westendorf AM; Breloer M; Probst-Kepper M; Fleischer B; Steinkasserer A; Buer J; Hansen W
J Immunol; 2008 May; 180(9):5890-7. PubMed ID: 18424708
[TBL] [Abstract][Full Text] [Related]
17. CD83 regulates splenic B cell maturation and peripheral B cell homeostasis.
Lüthje K; Kretschmer B; Fleischer B; Breloer M
Int Immunol; 2008 Aug; 20(8):949-60. PubMed ID: 18544574
[TBL] [Abstract][Full Text] [Related]
18. Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression.
Fries B; Heukeshoven J; Hauber I; Grüttner C; Stocking C; Kehlenbach RH; Hauber J; Chemnitz J
J Biol Chem; 2007 Feb; 282(7):4504-4515. PubMed ID: 17178712
[TBL] [Abstract][Full Text] [Related]
19. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell CD83: a therapeutic target or innocent bystander?
Prazma CM; Tedder TF
Immunol Lett; 2008 Jan; 115(1):1-8. PubMed ID: 18001846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
